北米のヒアルロン酸市場 – 業界動向と2030年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

北米のヒアルロン酸市場 – 業界動向と2030年までの予測

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • North America
  • 350 ページ
  • テーブル数: 217
  • 図の数: 39

北米のヒアルロン酸市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2023 –2030
Diagram 市場規模(基準年)
USD 3,986.54 Million
Diagram Market Size (Forecast Year)
USD 7,960.24 Million
Diagram CAGR
%
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>北米のヒアルロン酸市場、グレード別(化粧品グレードおよび医薬品グレード)、タイプ別(加水分解ヒアルロン酸、アセチル化ヒアルロン酸ナトリウム、ヒアルロン酸ナトリウム)、用途別(美容、変形性関節症、医薬品 API、化粧品、眼科、その他)、エンドユーザー別(メディカル スパおよびビューティー センター、皮膚科クリニック、美容整形外科センター)、流通チャネル別(直接入札および小売販売)の 2030 年までの業界動向および予測。

ヒアルロン酸市場

北米ヒアルロン酸市場の分析と洞察

ヒアルロン酸は、主に美容およびスキンケア製品に使用されています。傷の回復を早め、顔のしわやシワ、肌の老化を軽減し、切り傷や火傷などを治します。ヒアルロン酸には肌の色を明るくするビタミン C が含まれています。ヒアルロン酸を含む美容製品は、保湿剤、クリーム、スキン トナー、美容液などの形で塗布すると肌に栄養を与えます。

ヒアルロン酸市場

ヒアルロン酸市場

データブリッジマーケットリサーチは、市場は2023年から2030年の予測期間に9.0%のCAGRで成長し、2022年の39億8,654万米ドルから2030年には79億6,024万米ドルに達すると分析しています。

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2020~2016年にカスタマイズ可能)

定量単位

収益(百万米ドル)

対象セグメント

グレード(化粧品グレードおよび医薬品グレード)、タイプ(加水分解ヒアルロン酸、アセチル化ヒアルロン酸ナトリウム、ヒアルロン酸ナトリウム)、用途(美容、変形性関節症、医薬品 API、化粧品、眼科、その他)、エンドユーザー(メディカル スパおよびビューティー センター、皮膚科クリニック、美容外科センター)、流通チャネル(直接入札および小売販売)別。

対象国

米国、カナダ、メキシコ。

対象となる市場プレーヤー

Fidia Farmaceutici SpA、AbbVie、Bloomage Biotechnology Co., Ltd.、GALDERMA、LG Chem、Anika Therapeutics、Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America、Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies、Huons、Contipro as、Lifecore Biomedical、Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、SHANDONG TOPSCIENCE BIOTECH CO., LTD.、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Oceania International LLC が所有する Stanford Chemicals、Bioiberica SAU、GENESIS pharmacy services、Brickell Men's Products など

市場の定義

Hyaluronic Acid (HA) also called hyaluronan, is an anionic, non-sulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. An essential component of articular cartilage, hyaluronic acid surrounds each cell in the cartilage like a coat (chondrocyte). The robustness of cartilage is due to these aggregates' ingestion of water (its resistance to compression). The molecular weight (size) of hyaluronan in cartilage decreases with age, but the amount increases. The human body naturally contains HA. The largest quantities of HA are seen in the joints and eyes. The chemical has the capacity to maintain luscious, moisturized skin. As a result, it is used by many cosmetic surgeons as an injectable to delay the signs of aging on the skin.

The increasing prevalence of minimally invasive procedures and rising awareness and demand for hyaluronic acid in pharmaceutical and cosmetic products across the globe are major driving factors for market growth in the forecast period. The dramatic rise in the quality of research coupled with increasing research opportunities is because of various strategic initiatives taken by the market players. They are taking initiatives such as product launches, collaborations, mergers, acquisitions, and many more over the years and are expected to lead and create more opportunities in the market.

North America Hyaluronic Acid Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

  • Increasing Awareness Towards Cosmetic Injectables or Dermal Fillers

Hyaluronic acid-based dermal fillers are the less invasive cosmetic processes. Dermatology problems are common across the globe. It has become a major concern to understand the products to treat skin-related problems and restore skin wrinkles. Various programs have been launched to create awareness about the proper use of hyaluronic acid injectables.

The increased consciousness will enable the consumers to opt for the correct treatment of acne and wrinkles and to select the right product (Botox injection, dermal fillers) as per the correct cause. This will lead to a rise in sales, a rise in the product portfolio, and an expansion of the product line. This factor is expected to propel the market growth.

  • Use of Invasive Hyaluronic Acid Based Dermal Fillers

Hyaluronic acid-based dermal fillers are less invasive cosmetic processes, which are promptly increasing across the globe. These are popular cosmetic procedures for facial renovation, face volume restoration, and aesthetic improvement.

They are quite versatile and they are used on fine lines and wrinkles. In addition, these are also used for treating acne, wrinkles, and scars and for lip, cheek, and chin augmentation. The rise in the geriatric population has uplifted the necessity of non-invasive surgical protocols.

The implementation of hyaluronic acid-based dermal fillers will reduce the chances to opt for normal surgery. There is a minimum cost of treatment and this factor will boost the market growth.

RESTRAINTS

  • Availability of Unauthorized or Alternative Dermal Fillers to Hamper Market

With the widespread accessibility of the aesthetic application of Hyaluronic acid-based dermal fillers, several limiting factors of these products are projected to hamper the North America market growth in the coming years.

Due to the high efficacy rate, patient satisfaction, and usage in dynamic wrinkles, botulinum toxin type, a dermal filler, is leading the non-surgical cosmetic procedure worldwide.

Furthermore, other biodegradable fillers, such as Calcium Hydroxyapatite (CaHA) and Poly-L-Latic acid are gaining popularity as alternative fillers used as implants with high longevity.

The reluctance among physicians has been observed to use low-cost illegal products, due to the risks involved in it. Conversely, the illegal products being available in the dermal filler segment will increase the competition in price, especially in the hyaluronic acid segment. Larger companies that provide high prices per unit have the ability to compete by offering multiple product bundles and selling products among various product divisions.

To compensate for fewer prices in hyaluronic acid dermal fillers, the particle and polymer manufacturers will have to promote the products. The products available in the segment vary. The manufacturers will focus more on the material strength used in dermal fillers, rather than on the cost price.

OPPORTUNITIES

  • New Technology and Developments in Hyaluronic Acid Products

Advanced innovative technologies have improved aesthetic treatment for skin and other body parts wherever necessary and the skincare industry is one of the most rapidly changing ones. Homegrown brands with actives, ingredient-based skincare, and the beauty space are witnessing the rise of investment, and the consumer is keenly involved. The advanced innovative technology and developments of hyaluronic acid-based products boost the demand for hyaluronic acid in the market.

Hyaluronic dermal products are based on hyaluronic acid that corrects facial imperfections, compensates for volume, and emphasizes certain areas of the face. Advancement in dermal products offers an effective way to enhance, restore, and define facial features. Advancement in hyaluronic acid-based products and procedure of dermal fillers attracts customers toward cosmetics. Thus, it signifies that technological advancement in hyaluronic dermal products is expected to act as an opportunity for market growth.

CHALLENGES

  • Escalating Product Recall

ヒアルロン酸ベースの製品のリコールは、市場の成長に大きな影響を与えました。規制当局は、健康と安全の問題により、美容および化粧品をリコールしています。各国には、ヘルスケア関連製品の規制を監視する責任を負う独自の規制当局があります。

内容の不正確さや成分の誤りなど、患者の健康安全上の懸念から企業や規制当局が行う製品リコールは、患者の安全と健康が製品を市場に投入するあらゆる市場にとって最も重要な基準であるため、市場の成長に対する課題となる大きな懸念事項の一部です。

最近の動向

  • 2022年2月、アラガン社(アッヴィ社の子会社)は、21歳以上の成人の眼窩下窩の改善を目的としたJUVÉDERM VOLBELLA XCのFDA承認を発表しました。これにより、同社は米国市場における美容製品ポートフォリオを拡大することができました。
  • 2021年2月、チェコ共和国に拠点を置く有名なヒアルロン酸メーカーであるコンティプロは、肌の透明感を改善する新しいアンチエイジングおよび抗ニキビ治療製品「HyRetin」の発売を発表しました。

北米ヒアルロン酸市場の範囲

北米のヒアルロン酸市場は、グレード、タイプ、用途、エンドユーザー、流通チャネルに基づいて 5 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界のわずかな成長セグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供して、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

学年

  • 化粧品グレード
  • 医薬品グレード

グレードに基づいて、市場は化粧品グレードと医薬品グレードに分類されます。

タイプ

  • 加水分解ヒアルロン酸
  • アセチルヒアルロン酸ナトリウム
  • ヒアルロン酸ナトリウム

タイプに基づいて、市場は加水分解ヒアルロン酸、アセチル化ヒアルロン酸ナトリウム、ヒアルロン酸ナトリウムに分類されます。

応用

  • 美学
  • 変形性関節症
  • 医薬品API
  • 化粧品
  • 眼科
  • その他

用途に基づいて、市場は美容、変形性関節症、医薬品 API、化粧品、眼科、その他に分類されます。

エンドユーザー

  • 製薬業界
  • 皮膚科クリニック
  • 美容整形外科センター
  • その他

エンドユーザーに基づいて、市場は製薬業界、皮膚科クリニック、美容整形外科センターなどに分類されます。

流通チャネル

  • 直接入札
  • 小売販売

流通チャネルに基づいて、市場は直接入札と小売販売に分類されます。

北米ヒアルロン酸市場の地域分析/洞察    

北米のヒアルロン酸市場が分析され、上記のように国、グレード、タイプ、用途、エンドユーザー、流通チャネル別に市場規模の洞察と傾向が提供されます。

この市場レポートで取り上げられている国は、米国、カナダ、メキシコです。

  • 2023年には、米国が市場シェアと収益の面で北米のヒアルロン酸市場を支配し、予測期間中もその優位性を維持し続けるでしょう。これは、この地域での美容注射剤や皮膚充填剤に対する意識が高まっているためです。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規および交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争により直面する課題、販売チャネルの影響が考慮されています。

競争環境と北米ヒアルロン酸市場シェア分析

北米ヒアルロン酸市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、北米でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

北米のヒアルロン酸市場で活動している主要企業には、Fidia Farmaceutici SpA、AbbVie、Bloomage Biotechnology Co., Ltd.、GALDERMA、LG Chem、Anika Therapeutics, Inc.、Abbott、VIRCHOW BIOTECH、Kewpie Corporation、Merz North America, Inc.、LABORATOIRES FILLMED、Prollenium Medical Technologies.、Huons、Contipro as、Lifecore Biomedical, Inc.、BioScience GmbH、Teoxane、Bioxis Pharmaceuticals、SHANDONG TOPSCIENCE BIOTECH CO., LTD.、Bohus BioTech AB、RIVER PHARMA srl、Symatese、Oceania International LLC が所有する Stanford Chemicals、Bioiberica SAU、GENESIS pharmacy services、Brickell Men's Products などがあります。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA HYALURONIC ACID MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 GRADE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES

4.4 INDUSTRY INSIGHTS

5 REGULATORY FRAMEWORK

5.1 EGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN EUROPE

5.3 REGULATORY SCENARIO IN CHINA

5.4 REGULATORY SCENARIO IN AUSTRALIA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS

6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES

6.2 RESTRAINTS

6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET

6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES

6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION

6.3 OPPORTUNITIES

6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS

6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT

6.4 CHALLENGES

6.4.1 ESCALATING PRODUCT RECALL

6.4.2 LACK OF EXPERTISE

7 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE

7.1 OVERVIEW

7.2 COSMETIC GRADE

7.2.1 GENDER

7.2.1.1 FEMALE PRODUCTS

7.2.1.2 MEN’S PRODUCT

7.2.2 PRODUCT TYPE

7.2.2.1 SKIN CARE

7.2.2.2 MAKEUP

7.2.2.3 CLEANSING

7.2.2.4 HAIR CARE

7.2.2.5 OTHERS

7.2.3 PROCEDURE

7.2.3.1 WRINKLE REMOVAL

7.2.3.2 SKIN SMOOTHENING

7.2.3.3 FACE LIFT

7.2.3.4 LIP AUGMENTATION

7.2.3.5 CHIN AUGMENTATION

7.2.3.6 FAT INJECTION

7.2.3.7 FACE LINE CORRECTION

7.2.3.8 ACNE SCAR TREATMENT

7.2.3.9 LIP PLUM

7.2.3.10 EAR LOBE REJUVENATION

7.2.3.11 LIPOATROPHY TREATMENT

7.2.3.12 OTHERS

7.3 PHARMACEUTICAL GRADE

7.3.1 TYPE

7.3.1.1 MEDICAL GRADE HYALURONIC ACID

7.3.1.2 INJECTION GRADE HYALURONIC ACID

7.3.2 PRODUCT TYPE

7.3.2.1 TOPICAL PREPARATIONS

7.3.2.2 INTRA-ARTICULAR INJECTION

7.3.2.2.1 PREFILLED INJECTIONS

7.3.2.2.2 VIAL

7.3.2.3 EYE DROPS

7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS

7.3.2.5 OTHERS

8 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE

8.1 OVERVIEW

8.2 SODIUM HYALURONATE

8.2.1 MOLECULAR WEIGHT

8.2.1.1 HIGH MOLECULAR WEIGHT

8.2.1.2 LOW MOLECULAR WEIGHT

8.2.1.3 MEDIUM MOLECULAR WEIGHT

8.2.2 BY TYPE

8.2.2.1 COSMETIC GRADE

8.2.2.1.1 GENDER

8.2.2.1.1.1 FEMALE PRODUCTS

8.2.2.1.1.2 MEN'S PRODUCT

8.2.2.1.2 PRODUCT TYPE

8.2.2.1.2.1 SKIN CARE

8.2.2.1.2.2 MAKEUP

8.2.2.1.2.3 CLEANSING

8.2.2.1.2.4 HAIR CARE

8.2.2.1.2.5 OTHERS

8.2.2.2 PHARMACEUTICAL GRADE

8.2.2.2.1 TYPE

8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.2.2.2.2 PRODUCT TYPE

8.2.2.2.2.1 TOPICAL PREPARATIONS

8.2.2.2.2.2 INTRA-ARTICULAR INJECTION

8.2.2.2.2.2.1 PREFILLED INJECTIONS

8.2.2.2.2.2.2 VIAL

8.2.2.2.2.3 EYE DROPS

8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.2.2.2.2.5 OTHERS

8.3 HYDROLYZED HYALURONIC ACID

8.3.1 MOLECULAR WEIGHT

8.3.1.1 HIGH MOLECULAR WEIGHT

8.3.1.2 LOW MOLECULAR WEIGHT

8.3.1.3 MEDIUM MOLECULAR WEIGHT

8.3.2 BY TYPE

8.3.2.1 COSMETIC GRADE

8.3.2.1.1 GENDER

8.3.2.1.1.1 FEMALE PRODUCTS

8.3.2.1.1.2 MEN'S PRODUCT

8.3.2.1.2 PRODUCT TYPE

8.3.2.1.2.1 SKIN CARE

8.3.2.1.2.2 MAKEUP

8.3.2.1.2.3 CLEANSING

8.3.2.1.2.4 HAIR CARE

8.3.2.1.2.5 OTHERS

8.3.2.2 PHARMACEUTICAL GRADE

8.3.2.2.1 TYPE

8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.3.2.2.2 PRODUCT TYPE

8.3.2.2.2.1 TOPICAL PREPARATIONS

8.3.2.2.2.2 INTRA-ARTICULAR INJECTION

8.3.2.2.2.2.1 PREFILLED INJECTIONS

8.3.2.2.2.2.2 VIAL

8.3.2.2.2.3 EYE DROPS

8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.3.2.2.2.5 OTHERS

8.4 SODIUM ACETYLATED HYALURONIC ACID

8.4.1 MOLECULAR WEIGHT

8.4.1.1 HIGH MOLECULAR WEIGHT

8.4.1.2 LOW MOLECULAR WEIGHT

8.4.1.3 MEDIUM MOLECULAR WEIGHT

8.4.2 BY TYPE

8.4.2.1 COSMETIC GRADE

8.4.2.1.1 GENDER

8.4.2.1.1.1 FEMALE PRODUCTS

8.4.2.1.1.2 MEN'S PRODUCT

8.4.2.1.2 PRODUCT TYPE

8.4.2.1.2.1 SKIN CARE

8.4.2.1.2.2 MAKEUP

8.4.2.1.2.3 CLEANSING

8.4.2.1.2.4 HAIR CARE

8.4.2.1.2.5 OTHERS

8.4.2.2 PHARMACEUTICAL GRADE

8.4.2.2.1 TYPE

8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.4.2.2.2 PRODUCT TYPE

8.4.2.2.2.1 TOPICAL PREPARATIONS

8.4.2.2.2.2 INTRA-ARTICULAR INJECTION

8.4.2.2.2.2.1 PREFILLED INJECTIONS

8.4.2.2.2.2.2 VIAL

8.4.2.2.2.3 EYE DROPS

8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.4.2.2.2.5 OTHERS

9 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 AESTHETICS

9.3 OSTEOARTHRITIS

9.4 COSMETICS

9.5 OPHTHALMOLOGY

9.6 PHARMACEUTICAL API

9.7 OTHERS

10 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER

10.1 OVERVIEW

10.2 DERMATOLOGY CLINICS

10.3 COSMETIC SURGERY CENTERS

10.4 MEDICAL SPAS AND BEAUTY CENTERS

10.5 OTHERS

11 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL PHARMACY

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

12 NORTH AMERICA HYALURONIC ACID MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 FIDIA FARMACEUTICI S.P.A. (2022)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ABBVIE INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 GALDERMA

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 LG CHEM (2022)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ABBOTT (2022)

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ANIKA THERAPEUTICS, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 COMPANY SHARE ANALYSIS

15.7.4 PRODUCT PORTFOLIO

15.7.5 RECENT DEVELOPMENTS

15.8 BIOSCIENCE GMBH

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIOXIS PHARMACEUTICALS

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BIOIBERICA S.A.U

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BOHUS BIOTECH AB

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BRICKELL MEN'S PRODUCTS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CONTIPRO A.S.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 FILLMED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GENESIS

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 HUONS

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 KEWPIE CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 LIFECORE BIOMEDICAL, INC.(2022)

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 PROLLENIUM MEDICAL TECHNOLOGIES

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 RIVER PHARMA S.R.L.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 SYMATESE

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 TEOXANE

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 VIRCHOW BIOTECH

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

表のリスト

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 NORTH AMERICA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 NORTH AMERICA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 NORTH AMERICA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 NORTH AMERICA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 NORTH AMERICA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 NORTH AMERICA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 NORTH AMERICA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 NORTH AMERICA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 NORTH AMERICA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 NORTH AMERICA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 NORTH AMERICA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 NORTH AMERICA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 NORTH AMERICA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 NORTH AMERICA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 NORTH AMERICA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 NORTH AMERICA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 U.S. HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 U.S. COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 U.S. PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 U.S. HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 U.S. SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 U.S. COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 U.S. PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 U.S. HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 U.S. COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 U.S. PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 U.S. INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 U.S. SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 U.S. COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 U.S. PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 U.S. INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 U.S. HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 U.S. HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 U.S. HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 U.S. RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 CANADA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 CANADA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 CANADA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 CANADA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 CANADA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 CANADA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 CANADA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 CANADA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 CANADA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 CANADA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 CANADA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 CANADA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 CANADA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 CANADA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 CANADA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 CANADA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 CANADA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 CANADA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 CANADA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 MEXICO HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 MEXICO COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 MEXICO PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 MEXICO HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 MEXICO SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 MEXICO COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 MEXICO PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 MEXICO HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 MEXICO COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 MEXICO PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 MEXICO INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 MEXICO SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 MEXICO COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 MEXICO PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 MEXICO INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 MEXICO HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 MEXICO HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 MEXICO HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 MEXICO RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

図表一覧

FIGURE 1 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA HYALURONIC ACID MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA HYALURONIC ACID MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA HYALURONIC ACID MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA HYALURONIC ACID MARKET: DBMR POSITION GRID

FIGURE 8 NORTH AMERICA HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA HYALURONIC ACID MARKET: END USER COVERAGE GRID

FIGURE 10 NORTH AMERICA HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA HYALURONIC ACID MARKET

FIGURE 14 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, 2022

FIGURE 15 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)

FIGURE 16 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, 2022

FIGURE 19 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)

FIGURE 20 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, 2022

FIGURE 23 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, 2022

FIGURE 27 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 NORTH AMERICA HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 NORTH AMERICA HYALURONIC ACID MARKET: SNAPSHOT (2022)

FIGURE 35 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2022)

FIGURE 36 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 NORTH AMERICA HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 NORTH AMERICA HYALURONIC ACID MARKET: GRADE (2023-2030)

FIGURE 39 NORTH AMERICA HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The North America Hyaluronic Acid Market is projected to grow at a CAGR of 9.0% during the forecast period by 2030.
The future market value of the North America Hyaluronic Acid Market is expected to reach USD 7,960.24 million by 2030.
The major players in the North America Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the North America Hyaluronic Acid Market are U.S., Canada, and Mexico.